Insecticides (India) Limited
Valuation (87/100) does the heavy lifting; momentum (10/100) is the drag.
Buy zoneOur blended model reads Insecticides (India) Limited as a Hold at 49/100. At ₹641.2 it trades below our blended DCF and relative-multiples fair value of ₹922.89, about 44% upside to that estimate — we read it as undervalued by 44%. On 13.9x trailing earnings it sits cheaper than the Basic Materials median of about 22.2x. The price is about 40% below its 52-week high of ₹1,068.79 and 21% above the low of ₹528.4. Financial health scores 66/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. It clears 6 of 13 investability checks, with durability 45, valuation 74 and momentum 10 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹738.31.
1-year price
EOD · 2026-07-3152-week range
-40.01% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold49Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 12.1%
- Pass: Low debt (D/E < 0.5): 0.13x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 19%
- Fail: Earnings growing: -16%
- Fail: Net margin ≥ 10%: 6.5%
- Pass: Current ratio > 1.5: 1.96
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 3.65
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter75.5%
- Institutions9.4%
- Public & other15.1%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 3.65.
Opportunities
- Revenue growing (19% YoY).
- Trading in our value buy zone versus sector peers.
- Well off its 52-week high — possible mean-reversion.
- Trades ~44% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
About Insecticides (India) Limited
Insecticides (India) Limited manufactures and distributes agrochemicals and pesticides for crop protection and nutrition in India and internationally. Its product portfolio includes fungicides, insecticides, herbicides, biologicals, and plant growth regulators, sold through distributors, retailers, and dealers under the Tractor brand.
Insecticides (India) Limited — frequently asked questions
Is Insecticides (India) Limited a buy, hold or sell?
StocksWizard currently rates Insecticides (India) Limited (INSECTICID) a Hold, based on a blended score of 49/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Insecticides (India) Limited's fair value?
Our blended DCF and relative-valuation model estimates Insecticides (India) Limited's fair value at about ₹922.89, versus a current price of ₹641.2 — roughly 44% upside. On that basis the stock looks undervalued by 44%.
Is Insecticides (India) Limited financially healthy?
Insecticides (India) Limited scores 66/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Insecticides (India) Limited's share price performed?
Insecticides (India) Limited is down 9% over three months, and last traded at ₹641.2. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.